- Home
- SOPH vs AXGN Comparison
SOPH vs AXGN Comparison
Compare SOPH & AXGN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | SOPH | AXGN |
|---|---|---|
| Founded | 2011 | N/A |
| Country | Switzerland | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Biotechnology: Electromedical & Electrotherapeutic Apparatus |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 330.4M | 1.4B |
| IPO Year | 2021 | N/A |
Fundamental Metrics
Financial Performance| Metric | SOPH | AXGN |
|---|---|---|
| Price | $4.74 | $32.84 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 1 | 9 |
| Target Price | $7.00 | ★ $33.67 |
| AVG Volume (30 Days) | 76.0K | ★ 901.7K |
| Earning Date | 11-04-2025 | 10-29-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | $73,297,000.00 | ★ $214,709,000.00 |
| Revenue This Year | $18.32 | $21.60 |
| Revenue Next Year | $15.61 | $15.83 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | 13.66 | ★ 18.72 |
| 52 Week Low | $2.58 | $9.22 |
| 52 Week High | $5.30 | $34.24 |
Technical Indicators
Market Signals| Indicator | SOPH | AXGN |
|---|---|---|
| Relative Strength Index (RSI) | 52.12 | 68.38 |
| Support Level | $4.50 | $28.98 |
| Resistance Level | $4.84 | $33.30 |
| Average True Range (ATR) | 0.22 | 1.55 |
| MACD | -0.03 | -0.08 |
| Stochastic Oscillator | 48.00 | 88.01 |
Price Performance
Historical ComparisonAbout SOPH SOPHiA GENETICS SA
Sophia Genetics SA is a healthcare technology company dedicated to establishing the practice of data-driven medicine as the standard of care and for life sciences research. It has built a cloud-based SaaS platform capable of analyzing data and generating insights from complex multimodal data sets and different diagnostic modalities. The Company had a physical presence in three countries outside of its headquarters in Switzerland: France, the United States, and Brazil.
About AXGN Axogen Inc.
Axogen Inc is engaged in the science, development, and commercialization of technologies for peripheral nerve regeneration and repair. The company provides clinically, economically effective repair solutions for surgeons and health care providers. Its products include Avance Nerve Graft, Axoguard Nerve Connector, Axoguard Nerve Protector, Axoguard Nerve Cap and Avive Soft Tissue Membrane. It also offers an Axotouch Two-Point Discriminator used to measure the innervation density of any surface area of the skin. Its products are available in the United States, Canada, Germany, the United Kingdom, Spain, South Korea, and several other countries.